01 May 2009
By:Ngoc Do, Jason Hansell, Thomas P. Farrell
Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
 |
01 May 2009
By:Raviraj Pillai, Pradeep Karatgi
Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.
|
01 February 2009
By:Maj-Britt Babbel, Bodo Fritzsching
During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.
|
01 January 2009
By:Maureen Mistry
A new excipient for orally disintegrating tablets not only imparts superior tablet characteristics, but has the added advantage of allowing users to maintain full control over their formulations, manufacturing processes and intellectual property.
|
17 December 2008
The application of oral disintegrating technologies to higher dose actives is a natural extension of this ease of delivery dosage form.
|
01 December 2008
By:Marina Levina, Ali R. Rajabi-Siahboomi
Research shows that both drug prescription and alcohol consumption increase within the elderly population. It is, therefore, necessary to fully understand the impact of alcohol consumption on solid oral dosage forms, especially extended release formulations.
|
01 June 2008
By:Noboru Hoshi, Akane Kida, Takashi Hayashi, Yuki Murakami
When drugs are encapsulated, electrification (the electrostatic charge of the capsule) may sometimes cause problems, such as capsule adhesion during transportation or dispersion of the capsule content in the filling process.
|
| 
